Accumulating evidence suggests that p62 is an important oncoprotein 45-47, particularly in pancreatic cancer, where p62 promotes tumor progression by stabilizing NRF2, which modulates the stress response and malignant phenotype 46. Here, SQSTM1 is linked to familial pancreatic carcinoma.